These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28506682)

  • 1. Colorectal cancer-inflammatory bowel disease nexus and felony of Escherichia coli.
    Khan AA; Khan Z; Malik A; Kalam MA; Cash P; Ashraf MT; Alshamsan A
    Life Sci; 2017 Jul; 180():60-67. PubMed ID: 28506682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota, inflammatory bowel disease and colorectal cancer.
    Quaglio AEV; Grillo TG; De Oliveira ECS; Di Stasi LC; Sassaki LY
    World J Gastroenterol; 2022 Aug; 28(30):4053-4060. PubMed ID: 36157114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Aminosalicylic acid downregulates the growth and virulence of Escherichia coli associated with IBD and colorectal cancer, and upregulates host anti-inflammatory activity.
    Zhang S; Fu J; Dogan B; Scherl EJ; Simpson KW
    J Antibiot (Tokyo); 2018 Nov; 71(11):950-961. PubMed ID: 30050110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct inflammatory and cytopathic characteristics of Escherichia coli isolates from inflammatory bowel disease patients.
    Jensen SR; Mirsepasi-Lauridsen HC; Thysen AH; Brynskov J; Krogfelt KA; Petersen AM; Pedersen AE; Brix S
    Int J Med Microbiol; 2015 Dec; 305(8):925-36. PubMed ID: 26522075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Alterations of Colorectal Cancer with Inflammatory Bowel Disease.
    Yashiro M
    Dig Dis Sci; 2015 Aug; 60(8):2251-63. PubMed ID: 25840920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysplasia and colorectal cancer in inflammatory bowel disease: a result of inflammation or an intrinsic risk?
    Breynaert C; Vermeire S; Rutgeerts P; Van Assche G
    Acta Gastroenterol Belg; 2008; 71(4):367-72. PubMed ID: 19317276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Mitochondria Dysfunction in Inflammatory Bowel Diseases and Colorectal Cancer.
    Kłos P; Dabravolski SA
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico prediction of escherichia coli proteins targeting the host cell nucleus, with special reference to their role in colon cancer etiology.
    Khan AA
    J Comput Biol; 2014 Jun; 21(6):466-75. PubMed ID: 24611522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of molecular pathways in inflammatory bowel disease associated with colorectal cancer development.
    Azer SA
    Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):271-81. PubMed ID: 23169309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoprevention for colon cancer: new opportunities, fact or fiction?
    Terhaar Sive Droste JS; Tuynman JB; Van Dullemen HM; Mulder CJ
    Scand J Gastroenterol Suppl; 2006; (243):158-64. PubMed ID: 16782636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation and colorectal cancer.
    Kraus S; Arber N
    Curr Opin Pharmacol; 2009 Aug; 9(4):405-10. PubMed ID: 19589728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E. coli and colon cancer: is mutY a culprit?
    Khan AA; Cash P
    Cancer Lett; 2013 Dec; 341(2):127-31. PubMed ID: 23933175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer in patients with inflammatory bowel disease: the true impact of the risk.
    Herszényi L; Barabás L; Miheller P; Tulassay Z
    Dig Dis; 2015; 33(1):52-7. PubMed ID: 25531497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients' knowledge and fear of colorectal cancer risk in inflammatory bowel disease.
    Lopez A; Collet-Fenetrier B; Belle A; Peyrin-Biroulet L
    J Dig Dis; 2016 Jun; 17(6):383-91. PubMed ID: 27129893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inflammatory bowel disease and colorectal cancer].
    Hisamatsu T
    Nihon Rinsho; 2014 Jan; 72(1):56-62. PubMed ID: 24597349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal Microbiota in Inflammatory Bowel Disease and Carcinogenesis: Implication for Therapeutics.
    Bruner SD; Jobin C
    Clin Pharmacol Ther; 2016 Jun; 99(6):585-7. PubMed ID: 26850686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From Inflammation to Cancer in Inflammatory Bowel Disease: Molecular Perspectives.
    Romano M; DE Francesco F; Zarantonello L; Ruffolo C; Ferraro GA; Zanus G; Giordano A; Bassi N; Cillo U
    Anticancer Res; 2016 Apr; 36(4):1447-60. PubMed ID: 27069120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational Risks from Mechanisms to Medicines.
    Porter RJ; Arends MJ; Churchhouse AMD; Din S
    J Crohns Colitis; 2021 Dec; 15(12):2131-2141. PubMed ID: 34111282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.